Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults.

Previous comparative analyses of people admitted to hospital for COVID-19 versus influenza evaluated the risk of death, hospital readmission, and a narrow set of health outcomes up to 6 months following infection.

The NIRSE-GAL study shows in real time the evolution of the coverage achieved by immunisation with Nirsevimab in children and compares RSV admissions in different population groups of children and adults in Galicia in Spain with previous years.

Since 2018, the work of the European Commission on vaccination has been guided by the Council Recommendation on strengthened cooperation against vaccine-preventable diseases. The aim of this report is to support possible policy developments in the future.

Influenza is not a single virus, but a collection of subtypes broken down into many different strains.

Protecting infants from RSV with new tools: vaccines for pregnant women and use of monoclonal antibodies have been approved for use in the European Union to prevent RSV among young children. Are those tools working?

With the support of Sanofi, the Influenza Diabetes Community conducted a communications campaign to raise awareness of the impact of influenza on diabetes patients.

Among 232 mechanically ventilated COVID-19 patients, 21.1% had known diabetes mellitus, whereas 16.9% in wave 2 had unknown diabetes mellitus.

Chaired by DG SANTE, EU Member States agreed on prioritising for 2024-2026: health promotion & prevention of non-communicable diseases; healthy longevity/lifelong prevention; vaccine-preventable diseases & vaccination; and long COVID, amongst others.

This webinar provides an overview of WHO resources available to support countries in developing/strengthening their programmes and highlight examples of national and regional good practices for seasonal influenza prevention and control.

On the first-ever Health Day at a COP, more than 40 million health professionals from around the globe joined the call to action by the WHO and civil society organizations, to prioritize health in climate negotiations at COP28.